Gordon K. Wilcock
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 29, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.
Journal: The journal of prevention of Alzheimer's disease
Published: October 07, 2025
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: October 01, 2025
A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease.
Journal: The journal of applied laboratory medicine
Published: September 25, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Journal: Nature genetics
Published: August 17, 2019
Commentary for Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer's Disease.
Journal: Chinese journal of integrative medicine
Published: July 24, 2019
Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
Journal: Journal of Alzheimer's disease : JAD
Published: January 15, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Journal: Nature genetics
Published: March 12, 2018
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.
Journal: Journal of Alzheimer's disease : JAD
Published: November 21, 2017
Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients.
Journal: Current Alzheimer research
Published: January 19, 2017
Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study.
Journal: Dementia and geriatric cognitive disorders extra
Published: December 07, 2016
Last Updated: 09/26/2026